Transgenic Mouse Models of Angiogenesis and Lymphangiogenesis

International Review of Cell and Molecular Biology

Volumn 266, Issue , 2008, Pages 1-35

  Ribatti, Domenico ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

Author keywords

Angiogenesis; Endothelium; Lymphangiogenesis; Transgenic mouse models; Vascular system

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR 2; EPHRIN RECEPTOR B1; FIBROBLAST GROWTH FACTOR 2; FIBRONECTIN; GROWTH FACTOR; HYPOXIA INDUCIBLE FACTOR 1; NETRIN; NEUROPILIN; NOTCH RECEPTOR; PLACENTAL GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN; SONIC HEDGEHOG PROTEIN; THROMBOPLASTIN; TIE 1 RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN B; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3; GROWTH FACTOR RECEPTOR; SIGNAL PEPTIDE;

ANGIOGENESIS; CELL MIGRATION; ENDOTHELIUM CELL; GENE TARGETING; HUMAN; LYMPHANGIOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TRANSGENIC MOUSE; ANIMAL; ANIMAL MODEL; BLOOD VESSEL; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; GENETICS; LYMPH VESSEL; METABOLISM; MOUSE; PHYSIOLOGY; PRENATAL DEVELOPMENT;

MURINAE; MUS; MUS MUSCULUS;

ANIMALS; BLOOD VESSELS; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHANGIOGENESIS; LYMPHATIC VESSELS; MICE; MICE, TRANSGENIC; MODELS, ANIMAL; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTORS, GROWTH FACTOR;

EID: 48949087167     PISSN: 19376448     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1937-6448(07)66001-8     Document Type: Review

References (164)

1. Achen M.G., Jeltsch M., Kukk E., Makinen T., Vitali A., Wilks A.F., Alitalo K., and Stacker S.A. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc. Natl. Acad. Sci. USA 95 (1998) 548-553
2. Achen M.G., Williams R.A., Baldwin M.E., Lai P., Roufail S., Alitalo K., and Stacker S.A. The angiogenic and lymphangiogenic factor vascular endothelial growth factor-D exhibits a paracrine mode of action in cancer. Growth Factors 20 (2002) 99-107
3. Adams R.H., and Klein R. Eph receptors and ephrin ligands: Essential mediators of vascular development. Trends Cardiovasc. Med. 10 (2000) 183-188
4. Adams R.H., Wilkinson G.A., Weiss C., Diella F., Gale N.W., Deutsch U., Risau W., and Klein R. Roles of ephrinB ligands and EphB receptors in cardiovascular development: Demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev. 13 (1999) 295-306
5. Airoldi I., Di Carlo E., Cocco C., Taverniti G., D'Antuono T., Ognio E., Watanabe M., Ribatti D., and Pistoia V. Endogenous IL-12 triggers an antiangiogenic program in melanoma cells. Proc. Natl. Acad. Sci. USA 104 (2007) 3996-4001
6. Armulik A., Abramsson A., and Betsholtz C. Endothelial/pericyte interactions. Circ. Res. 97 (2005) 512-523
7. Arthur H.M., Ure J., Smith A.J., Renforth G., Wilson D.I., Torsney E., Charlton R., Parums D.V., Jowett T., Marchuk D.A., Burn J., and Diamond A.G. Endoglin, an ancillary TGF-β receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. Dev. Biol. 217 (2000) 42-53
8. Ausprunk D.H., Dethlefsen S.M., and Higgin E.R. Distribution of fibronectin, laminin and type IV collagen during development of blood vessels in the chick chorioallantoic membrane. In: Feinberg R.N., Sherer G.K., and Auerbach R. (Eds). "The Development of the Vascular System". "Issues in Biomedicine," Vol. 14 (1991), S. Karger, Basel 93-108
9. Baldwin M.E., Halford M.M., Roufail S., Williams R.A., Hibbs M.L., Grail D., Kubo H., Stacker S.A., and Achen M.G. Vascular endothelial growth factor D is dispensable for development of the lymphatic system. Mol. Cell. Biol. 25 (2005) 2441-2449
10. Baron M., Aslam H., Flasza M., Fostier M., Higgs J.E., Mazaleyrat S.L., and Wilkins M.B. Multiple levels of Notch signal regulation [review]. Mol. Membr. Biol. 19 (2002) 27-38
11. Bellomo D., Headrick J.P., Silins G.U., Paterson C.A., Thomas P.S., Gartside M., Mould A., Cahill M.M., Tonks I.D., Grimmond S.M., Townson S., Wells C., et al. Mice lacking the vascular endothelial growth factor-B gene (vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery after cardiac ischemia. Circ. Res. 86 (2000) E29-E35
12. Bertolino P., Deckers M., Lebrin F., and ten Dijke P. Transforming growth factor-β signal transduction in angiogenesis and vascular disorders. Chest 128 6 Suppl. (2005) 585S-590S
13. Bikfalvi A., and Han Z.C. Angiogenic factors are hematopoietic factors and vice versa. Leukemia 8 (1994) 523-529
14. Burri P.H., and Tarek M.R. A novel mechanism of capillary growth in the rat pulmonary microcirculation. Anat. Rec. 228 (1990) 35-45
15. Byrd N., Becker S., Maye P., Narasimhaiah R., St Jacques B., Zhang X., McMahon J., McMahon A., and Grabel L. Hedgehog signaling is essential for yolk sac vasculogenesis. Development 129 (2002) 361-372
16. Cao Y., and Xue L. Angiostatin. Semin. Thromb. Hemost. 30 (2004) 83-93
17. Cao Y., Linden P., Farnebo J., Cao R., Eriksson A., Kumar V., Qi J.H., Claesson-Welsh L., and Alitalo K. Vascular endothelial growth factor C induces angiogenesis in vivo. Proc. Natl. Acad. Sci. USA 95 (1998) 14389-14394
18. Carmeliet P., Ferreira V., Breier G., Pollefeyet S., Kieckens L., Gertsenstein M., Fahrig M., Vandenhoeck A., Harpal K., Eberhardt C., Declercq C., Pawling J., et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380 (1996) 435-439
19. Carmeliet P., Mackman N., Moons L., Luther T., Gressens P., Van Vlaenderen I., Demunck H., Kasper M., Breier G., Evrard P., Miller M., Risau W., et al. Role of tissue factor in embryonic blood vessel development. Nature 383 (1996) 73-75
20. 188. Nat. Med. 5 (1999) 495-502
21. Carmeliet P., Lampugnani M.G., Moons L., Breviarion F., Compernolle V., Bono F., Balconi G., Spagnuolo R., Oostuyse B., Dewerchin M., Zanetti A., Angellilo A., et al. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 98 (1999) 147-157
22. Carmeliet P., Moons L., Luttun A., Vincenti V., Compernolle V., De Mol M., Wu Y., Bono F., Devy L., Beck H., Scholz D., Acker T., et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat. Med. 7 (2001) 575-583
23. Cox C.M., and Poole T.J. Angioblast differentiation is influenced by the local environment: FGF-2 induces angioblasts and pattern vessel formation in the quail embryo. Dev. Dyn. 218 (2000) 371-382
24. Crosby C.V., Fleming P.A., Argraves W.S., Corada M., Zanetta L., Dejana E., and Drake C.J. VE-cadherin is not required for the formation of nascent blood vessels but acts to prevent their disassembly. Blood 105 (2005) 2771-2776
25. Davis S., and Yancopoulos G.F. The angiopoietins: Yin and yang in angiogenesis. Curr. Top. Microbiol. Immunol. 273 (1999) 173-185
26. De Falco S., Gigante B., and Persico M.G. Structure and function of placental growth factor. Trends Cardiovasc. Med. 12 (2002) 241-246
27. Delafontaine P. Insulin-like growth factor I and its binding proteins in the cardiovascular system. Cardiovasc. Res. 30 (1995) 825-834
28. 1 knock out mice. Development 121 (1995) 1845-1854
29. Drake C.J., and Fleming P.A. Vasculogenesis in the day 6.5 to 9.5 mouse embryo. Blood 95 (2000) 1761 1679
30. Drake C.J., and Little C.D. Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic neovascularization. Proc. Natl. Acad. Sci. USA 92 (1995) 7657-7761
31. Drake C.J., Davis L.A., Walters L., and Little C.D. Avian vasculogenesis and the distribution of collagens I, IV, laminin, and fibronectin in the heart primordia. J. Exp. Zool. 255 (1990) 309-322
32. Duarte A., Hirashima M., Benedito R., Trindade A., Diniz P., Bekman E., Costa L., Henrique D., and Rossant J. Dosage-sensitive requirement for mouse Dll4 in artery development. Genes Dev. 18 (2004) 2474-2478
33. Dumont D.J., Fong G.H., Puri M.C., Gradwohl G., Alitalo K., and Breitman M.L. Vascularization of the mouse embryo: Study of flk-1, tek, tie and vascular endothelial growth factor expression during development. Dev. Dyn. 203 (1995) 80-92
34. Dumont D.J., Jussila L., Taipale J., Mustonen T., Pajusola K., Breitman M., and Alitalo K. Failure of cardiovascular development in embryos deficient of the lymphatic vascular endothelial growth factor-C receptor, VEGFR-3. Science 282 (1998) 946-949
35. Ema M., Faloon P., Zhang W.J., Hirashima M., Reid T., Stanford W.L., Orkin S., Choi K., and Rossant J. Combinatorial effects of Flk-1 and Tal-1 on vascular and hematopoietic development in the mouse. Genes Dev. 17 (2003) 380-393
36. Enholm B., Karpanen T., Jeltsch M., Kubo H., Stenback F., Prevo R., Jackson D.G., Yla-Herttuala S., and Alitalo K. Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin. Circ. Res. 88 (2001) 623-629
37. Ezekowitz R.A., Mulliken J.B., and Folkman J. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N. Engl. J. Med. 326 (1992) 1456-1463
38. Ferrara N., Carver-Moore K., Chen H., Dowd M., Lu L., O'Shea K.S., Powell-Braxton L., Hillan K.J., and Moore M.W. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380 (1996) 439-442
39. Ferrara N., Chen H., Davis-Smyth T., Gerber H.P., Nguyen T.N., Peers D., Chisholm V., Hillan K.J., and Schwall R.H. Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nat. Med. 4 (1998) 336-340
40. Flamme I., and Risau W. Induction of vasculogenesis and hematopoiesis in vitro. Development 116 (1992) 435-439
41. Flamme I., Frolich T., and Risau W. Molecular mechanisms of vasculogenesis and embryonic angiogenesis. J. Cell Physiol. 173 (1997) 206-210
42. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1 (1995) 27-31
43. Folkman J. Antiangiogenesis in cancer therapy: Endostatin and its mechanism of action. Exp. Cell Res. 312 (2006) 594-607
44. Fong G.H., Rossant J., Gertsenstein M., and Breitman M.L. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376 (1995) 66-70
45. Fong G.H., Zhang L., Bryce D.M., and Peng J. Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice. Development 126 (1999) 3015-3025
46. Foo S.S., Turner C.J., Adams S., Compagni A., Aubyn D., Kogata N., Lindblom P., Shani M., Zicha D., and Adams R.H. Ephrin-B2 control cell motility and adhesion during blood vessel wall assembly. Cell 124 (2006) 161-173
47. Fulgham D.L., Widhalm S.R., Martin S., and Coffin J.D. FGF-2 dependent angiogenesis is a latent phenotype in basic fibroblast growth factor transgenic mice. Endothelium 6 (1999) 185-195
48. Gale N.W., Dominguez M.G., Noguera I., Pan L., Hughes V., Valenzuela D.M., Murphy A.J., Adams N.C., Lin H.C., Holash J., Thurston G., and Yancopoulos G.D. Haploinsufficency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development. Proc. Natl. Acad. Sci. USA 101 (2004) 15949-15954
49. George E.L., Georges-Labouesse E.N., Patel-King R.S., Rayburn H., and Hynes R.O. Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development 119 (1993) 1079-1091
50. Gerber H.P., Hillan K.J., Ryan A.M., Kowalski J., Keller G.A., Rangell L., Wright B.D., Radtke F., Aguet M., and Ferrara N. VEGF is required for growth and survival in neonatal mice. Development 126 (1999) 1149-1159
51. Gerber H.P., Vu T.H., Ryan A.M., Kowalski J., Werb B., and Ferrara N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat. Med. 5 (1999) 623-628
52. Gerety S.S., and Anderson D.J. Cardiovascular ephrin-B2 is essential for embryonic angiogenesis. Development 129 (2002) 1397-1410
53. Gerety S.S., Wang H.U., Chen Z.F., and Anderson D.J. Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development. Mol. Cell. 4 (1999) 403-414
54. Gerhardt H., Ruhrberg C., Abramsson A., Fujisawa H., Shima D., and Betsholtz C. Neuropilin-1 is required for endothelial tip cell guidance in the developing central nervous system. Dev. Dyn. 231 (2004) 503-509
55. Giger R.J., Clouitier J.F., Sahay A., Prinjha R.K., Levengood D.V., Moore S.E., Pickering S., Simmons D., Ratsan S., Walsh F.S., Kolodkin A.L., Ginty D.D., et al. Neuropilin-2 is required in vivo for selective axon guidance responses to secreted semaphorins. Neuron 25 (2000) 29-41
56. Gitler A.D., Lum M., and Epstein J.A. Plexin D1 and semaphorin signaling are required in endothelial cells for cardiovascular development. Dev. Cell 7 (2004) 107-116
57. Gory-Faure S., Prandini M.H., Pointu H., Roullot V., Pignot-Paintrand I., Vernet M., and Huber P. Role of vascular endothelial-cadherin in vascular morphogenesis. Development 126 (1999) 2093-2102
58. Gu C., Rodriguez E.R., Reimert D.V., Shu T., Fritzsch B., Richards L.J., Kolodkin A.L., and Ginty D.D. Neuropilin-1 conveys semaphorin and VEGF signaling during neural and cardivascular development. Dev. Cell 5 (2003) 45-57
59. Gu C., Yoshida Y., Livet J., Reimert D.V., Mann F., Merte J., Henderson C.E., Jessell T.M., Kolodkin A.L., and Ginty D.D. Semaphorin 3E and plexin-D1 control vascular pattern independently of neuropilins. Science 307 (2005) 265-268
60. Gutner G.C., Davis V., Li H., McCoy M.J., Sharpe A., and Cybulsky M.I. Targeted disruption of the murine VCAM1 gene: Essential role of VCAM-1 in chorioallantoic fusion and placentation. Genes Dev. 9 (1995) 1-14
61. Hanahan D., and Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86 (1996) 353-364
62. Handsley M.M., and Edwards D.R. Metalloproteinases and their inhibitors in tumor angiogenesis. Int. J. Cancer 115 (2005) 849-860
63. Hellstrom M., Kalen M., Lindahl P., Abramson A., and Betsholtz C. Role of PDGF-B and PDGFR-β in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 126 (1999) 3047-3055
64. Hellstrom M., Phng L.K., Hofmann J.J., Wallgard E., Coultas L., Lindblom P., Alva J., Nilsson A.K., Karlsson L., Gaiano N., Yoon K., Rossam J., et al. Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature 445 (2007) 776-780
65. Hodivala-Dilke K.M., McHugh K.P., Tsakiris D.A., Rayburn H., Crowley D., Ullman-Cullere M., Ross F.P., Coller B.S., Teitelbaum S., and Hynes R.O. β3-Integrin-deficient mice are a model for Glanzmann thromboasthenia showing placental defects and reduced survival. J. Clin. Invest. 103 (1999) 229-238
66. Hynes R.O., Bader B.L., and Hodivala-Dilke K. Integrins in vascular development. Braz. J. Med. Biol. Res. 32 (1999) 501-510
67. Iruela-Arispe M.L., Luque A., and Lee N. Thrombospondin modulates angiogenesis. Int. J. Biochem. Cell Biol. 36 (2004) 1070-1078
68. Iso T., Hamamori Y., and Kedes L. Notch signaling in vascular development. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 543-553
69. 2 homeostasis by hypoxia-inducible factor 1α. Genes Dev. 12 (1998) 149-162
70. Jeltsch M., Kaipainen A., Joukov V., Meng X., Lakso M., Rauvala H., Swartz M., Fukumura D., Jain R.K., and Alitalo K. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276 (1997) 1423-1425
71. Joukov V., Pajusola K., Kaipainen A., Chilov D., Lahtinen I., Kukk E., Saksela O., Kalkkinen N., and Alitalo K. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J. 15 (1996) 290-298
72. Kaipainen A., Korhoen J., Mustonen T., van Hinsberg V.W.M., Fang G.H., Dumont D., Breitman M., and Alitalo K. Expression of the fms-like tyrosine kinase gene becomes restricted to lymphatic endothelium during development. Proc. Natl. Acad. Sci. USA 92 (1995) 3566-3570
73. Karkkainen M.J., Saaristo A., Jussila L., Karila K.A., Lawrence E.C., Pajusola K., Bueler H., Eichmann A., Kauppinen R., Kettunen M.I., Yla-Herttuala S., Finegold D.N., et al. A model for gene therapy of human hereditary lymphedema. Proc. Natl. Acad. Sci. USA 98 (2001) 12677-12682
74. Karkkainen M.J., Haiko P., Sainio K., Partanen J., Taipale J., Petrova T.V., Jeltsch M., Jackson D.G., Talikka M., Rauvala H., Betsholtz C., and Alitalo K. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat. Immunol. 5 (2004) 74-80
75. Karpanen T., Heckman C.A., Keskitalo S., Jeltsch M., Ollila H., Neufeld G., Tamagnone L., and Alitalo K. Functional interactions of VEGF-C and VEGF-D with neuropilin receptors. FASEB J. 20 (2006) 1462-1472
76. Kawasaki T., Kitsukawa T., Bekku Y., Matsuda Y., Sanbo M., Yagi T., and Fujisawa H. A requirement for neuropilin-1 in embryonic vessel formation. Development 126 (1999) 4895-4902
77. Kitsukawa T., Shimono A., Kawakami A., Kondoh H., and Fujisawa H. Overexpression of a membrane protien, neuropilin, in chimeric mice causes anomalies in the cardiovascular system and limbs. Development 121 (1995) 4309-4318
78. Kitsukawa T., Shimizu M., Sanbo M., Hirata T., Tanigucih M., Bekku Y., Yagi T., and Fujisawa H. Neuropilin-semaphorin III/D-mediated chemorepulsive signals play a crucial role in peripheral nerve projection in mice. Neuron 19 (1997) 995-1005
79. Kluk M.J., and Hla T. Signaling of sphingosine-1-phosphate via the S1P/EDG-family of G-protein-coupled receptors. Biochim. Biophys. Acta 1582 (2002) 72-80
80. Koch A.E., Polverini P.J., Kunkel S.L., Harlow L.A., Di Pietro L.A., Elner V.M., Elner S.G., and Strieter R.M. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258 (1992) 1798-1801
81. Kono M., Mi Y., Liu Y., Sasaki T., Allende M.L., Wu Y.P., Yamashita T., and Proia R.L. The sphingosine-1-phosphate receptors S1P1, S1P2 and S1P3 function coordinately during embryonic angiogenesis. J. Biol. Chem. 279 (2004) 29367-29373
82. Kotch L.E., Iyer N.V., Laughner E., and Semenza G.L. Defective vascularization of HIF-1α-null embryos is not associated with VEGF deficiency but with mesenchymal cell death. Dev. Biol. 191 (1999) 297-305
83. Krebs L.T., Xue Y., Norton C.R., Shutter J.R., Maguire M., Sundberg J.P., Gallahan D., Closson V., Kitajewski J., Callahan R., Smith G.H., Stark K.L., et al. Notch signaling is essential for vascular morphogenesis in mice. Genes Dev. 14 (2000) 1342-1352
84. Kruger R.P., Aurandt J., and Guan K.L. Semaphorins command cells to move. Nat. Rev. Mol. Cell Biol. 6 (2005) 789-800
85. Kwee L., Baldwin H.S., Shen H.M., Stewart C.L., Buck C., Buck C.A., and Labow M.A. Defective development of the embryonic and extraembryonic circulatory systems in vascular cell adhesion molecule (VCAM-1) deficient mice. Development 121 (1995) 489-503
86. Lampugnani M.G., Resnati M., Raiteri M., Pigott R., Pisacane A., Houen G., Ruco L.P., and Dejana E. A novel endothelial-specific membrane protein is a marker of cell-cell contact. J. Cell Biol. 118 (1992) 1511-1522
87. Larsson J., Goumans M.J., Sjostrand L.J., van Rooijen M.A., Ward D., Levéen P., Xu X., ten Dijke P., Mummery C.L., and Karlsson S. Abnormal angiogenesis by intact hematopoietic potential in TGF-β type I receptor-deficient mice. EMBO J. 20 (2001) 1663-1673
88. Leibovich S.J., Polverini P.J., Shepard H.M., Wiseman D.M., Shively V., and Nuiser N. Macrophage-induced angiogenesis is mediated by tumor necrosis factor α. Nature 329 (1987) 630-632
89. 165 in Cre-activated transgenic mice. PloS ONE 1 (2006) 1-8
90. Li D.Y., Sorensen L.K., Brooke B.S., Urness L.D., Davis E.C., Taylor D.G., Boak B.B., and Wendel D.P. Defective angiogenesis in mice lacking endoglin. Science 284 (1999) 1534-1537
91. Liaw C.W., Cannon C., Power M.D., Kiboneka P.K., and Rubin L.L. Identification and cloning of two species of cadherins in bovine endothelial cells. EMBO J. 9 (1990) 2701-2708
92. Lindahl P., Johansson B.R., Leeven P., and Betsholtz C. Pericyte loss and microaneurysm formation in PDGF-B-dependent mice. Science 277 (1997) 242-245
93. Lindahl P., Hellstrom M., Kalen M., Karlsson L., Pekny M., Pekna M., Soriano P., and Betsholtz C. Paracrine PDGF-B/PDGF-R β signaling controls mesangial cell development in kidney glomeruli. Development 125 (1998) 3313-3322
94. Liu Y., Wada R., Yamashita T., Mi Y., Deng C.X., Hobson J.P., Rosenfeldt H.M., Nava V.E., Chae S.S., Lee M.J., Liu C.H., Hla T., et al. Edg-1, the G-protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J. Clin. Invest. 106 (2000) 951-961
95. Lobov I.B., Renard R.A., Papadopoulos N., Gale N.W., Thurston G., Yancopoulos G.D., and Wiegand S.J. Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting. Proc. Natl. Acad. Sci. USA 104 (2007) 3219-3224
96. Lu X., Le Noble F., Yuan L., Jiang Q., De Lafarge B., Sugiyama D., Breant C., Claes F., De Smet F., Thomas J.L., Autiero M., Carmeliet P., et al. The netrin receptor UNC5B mediates guidance events controlling morphogenesis of the vascular system. Nature 432 (2004) 179-186
97. Maisonpierre P.C., Suri C., Jines P.F., Bartunkova S., Wiegand S.J., Radziejewski C., Compton D., McClain J., Aldrich T.H., Papadopoulos N., Daly T.J., Davis S., et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277 (1997) 55-60
98. Makinen J., Jussila L., Veikkola T., Karpanen T., Kettunen M.I., Pulkkanen K.J., Kauppinen R., Jackson D.G., Kubo H., Nishikawa S., Yla-Herttuala S., and Alitalo K. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat. Med. 7 (2001) 199-205
99. Mandriota S.J., Jussila L., Jeltsch M., Compagni A., Baetens D., Prevo R., Banerji S., Huarte J., Montesano R., Jackson D.G., Orci L., Alitalo K., et al. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J. 20 (2001) 672-682
100. Marconcini L., Marchio S., Morbidelli L., Cartocci E., Albini A., Ziche M., Bussolino F., and Oliviero S. c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro. Proc. Natl. Acad. Sci. USA 96 (1999) 9671-9676
101. McMahon A.P., Ingham P.W., and Tabin C.J. Developmental roles and clinical significance of hedgehog signaling. Curr. Top. Dev. Biol. 53 (2003) 1-114
102. Montrucchio G., Alloatti G., and Camussi G. Role of platelet-activating factor in cardiovascular pathophysiology. Physiol. Rev. 80 (2000) 1669-1699
103. Murray P. The physiological principle of minimum: The vascular system and the cost of blood volume. Proc. Natl. Acad. Sci. USA 12 (1926) 207-214
104. Neufeld G., Cohen T., Shraga N., Lange T., Kessler O., and Herzog Y. The neuropilins: Multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis. Trends Cardiovasc. Med. 12 (2002) 13-19
105. Nezu E., Ohashi Y., Kinoshita S., and Manabe R. Recombinant human epidermal growth factor and corneal neovascularization. Jpn. J. Ophthalmol. 36 (1992) 401-406
106. Nilsson M.B., Langley R.R., and Fidler I.J. Interleukin-6, secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine. Cancer Res. 65 (2005) 10794-10800
107. Oh S.J., Jeltsch M.M., Birkenhäger R., McCarthy J.E., Weich H.A., Christ B., Alitalo K., and Wilting J. VEGF and VEGF-C: Specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev. Biol. 188 (1997) 96-109
108. 1 signaling in the regulation of angiogenesis. Proc. Natl. Acad. Sci. USA 97 (2000) 2626-2631
109. Olofsson B., Jeltsch M., Eriksson U., and Alitalo K. Current biology of VEGF-B and VEGF-C. Curr. Opin. Biotechnol. 10 (1999) 528-535
110. Oshima M., Oshima H., and Taketo M.M. TGF-β receptor type II deficency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev. Biol. 179 (1996) 297-302
111. Ozaki H., Okamoto N., Ortega S., Chang M., Ozaki K., Sadda S., Vinores M.A., Derevjanik N., Zack D.J., Basilico C., and Campochiaro P.A. Basic fibroblast growth factor is neither necessary nor sufficient for the development of retinal neovascularization. Am. J. Pathol. 153 (1998) 757-765
112. Park J.E., Chen H.H., Winer J., Houck K.A., and Ferrara N. Placenta growth factor: Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J. Biol. Chem. 269 (1994) 25646-25654
113. Partanen J., Puri M.C., Schwartz L., Fisher K.D., Bernstein A., and Rossant J. Cell autonomous functions of the receptor tyrosine kinase TIE in a late phase of angiogenic capillary growth and endothelial cell survival during murine development. Development 122 (1996) 3013-3021
114. Pasterkamp R.J., and Kolodkin A.L. Semaphorin junction: Making tracks toward nerla connectivity. Curr. Opin. Neurobiol. 13 (2003) 79-89
115. Pepper M.S., Montesano R., Mandriota S.J., Orci L., and Vassalli J.D. Angiogenesis: A paradigm for balanced extracellular proteolysis during cell migration and morphogenesis. Enzyme Protein 49 (1996) 138-162
116. Presta M., Dell'Era P., Mitola S., Moroni E., Ronca R., and Rusnati M. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev. 16 (2005) 159-178
117. Puri M.C., Partanen J., Rossant J., and Bernstein A. Interaction of the TEK and TIE receptor tyrosine kinases during cardiovascular development. Development 126 (1999) 4569-4580
118. Radice G.L., Rayburn H., Matsunami H., Knudsen K.A., Takeichi M., and Hynes R.O. Developmental defects in mouse embryos lacking N-cadherin. Dev. Biol. 181 (1997) 64-78
119. Ribatti D. The crucial role of vascular permeability factor/vascular endothelial growth factor in angiogenesis: A historical review. Br. J. Haematol. 128 (2005) 303-309
120. Ribatti D., Urbinati C., Nico B., Rusnati M., Roncali L., and Presta M. Endogenous basic fibroblast growth factor is implicated in the vascularization of the chick embryo chorioallantoic membrane. Dev. Biol. 170 (1995) 39-49
121. Ribatti D., Vacca A., Roccaro A.M., Crivellato E., and Presta M. Erythropoietin as an angiogenic factor. Eur. J. Clin. Invest. 33 (2003) 891-896
122. Risau W. Mechanisms of angiogenesis. Nature 386 (1997) 671-674
123. Risau W., and Flamme I. Vasculogenesis. Annu. Rev. Cell Dev. Biol. 11 (1995) 73-91
124. Risau W., and Lemmon D. Changes in the vascular extracellular matrix during embryonic vasculogenesis and angiogenesis. Dev. Biol. 125 (1988) 441-450
125. Rosen E.M., Lamszus K., Laterra J., Polverini P.J., Rubin J.S., and Goldberg I.D. HGF/SF in angiogenesis. Ciba Found. Symp. 212 (1997) 215-226
126. Ruhrberg C., Gerhardt H., Golding M., Watson R., Ionnidou S., Fujisawa H., Betsholtz C., and Shima D.T. Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. Genes Dev. 16 (2002) 2684-2696
127. Ryan H.E., Lo J., and Johnson R.S. HIF-1α is required for solid tumor formation and embryonic vascularization. EMBO J. 17 (1998) 3005-3015
128. Sainson R.C., Aoto J., Nakatsu M.N., Holderfield M., Conn E., Koller E., and Hughes C.C. Cell-autonomous notch signaling regulates endothelial cell branching and proliferation during vascular tubulogenesis. FASEB J. 19 (2005) 1027-1029
129. Salomon D., Ayalon O., Patel-King R., Hynes R.O., and Geiger B. Extrajunctional distribution of N-cadherin in cultured human endothelial cells. J. Cell Sci. 102 (1992) 7-17
130. Sato T.N., Tozawa Y., Deutsch U., Wolburg-Buchholz K., Fujiwara Y., Gendron-Maguire M., Gridley T., Wolburg H., Risau W., and Qin Y. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376 (1995) 70-74
131. 2 hemostasis by hypoxia-inducible factor-1. Annu. Rev. Cell Dev. Biol. 15 (1999) 551-578
132. Serafini T., Kennedy T.E., Galko M.J., Mirzayan C., Jessell T.M., and Tessier-Lavigne M. The netrins define a family of axon outgrowth-promoting proteins homologous to C. elegans UNC-6. Cell 78 (1994) 409-424
133. Shalaby F., Rossant J., Yamaguchi T.P., Gertsenstein M., Wu X.F., Breitman M.L., and Schuh A.C. Failure of blood island formation and vasculogenesis in Flk-1-deficient mice. Nature 376 (1995) 62-66
134. Shalaby F., Ho J., Stanford W.L., Fischer K.D., Schuh A.C., Schwartz L., Bernstein A., and Rossant J. A requirement for Flk-1 in primitive and definitive hematopoiesis and vasculogenesis. Cell 89 (1997) 981-990
135. Shawber C.J., and Kitajewski I. Notch function in the vasculature: Insights from zebrafish, mouse and man. Bioessays 26 (2004) 225-234
136. Soriano P. Abnormal kidney development and hematological disorders in PDGF β-receptor mutant mice. Genes Dev. 8 (1994) 1888-1896
137. Spiegel S., and Milstein S. Sphingosine-1-phosphate: An enigmatic signalling lipid. Nat. Rev. Mol. Cell Biol. 4 (2003) 397-407
138. Stacker S.A., Caesar C., Baldwin M.E., Thornton G.E., Williams R.A., Prevo R., Jackson D.G., Nishikawa S., Kubo H., and Achen M.G. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat. Med. 7 (2001) 186-191
139. Stalmans I., Ng Y.S., Rohan R., Fruttiger M., Bouché A., Yuce A., Fujisawa H., Hermans B., Shani M., Jansen S., Hicklin D., Anderson D.J., et al. Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. J. Clin. Invest. 109 (2002) 327-336
140. St Jacques B., Hammerschmidt M., and McMahon A.P. Indian Hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev. 13 (1999) 2072-2086
141. Suchting S., Freitas C., le Noble F., Benedito R., Breant C., Duarte A., and Eichmann A. The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching. Proc. Natl. Acad. Sci. USA 104 (2007) 3225-3230
142. Suri C., Jones P.F., Patan S., Bartunkova S., Maisonpierre P.C., Davis S., Sato T.N., and Yancopoulos G.D. Requisite role of angiopoietin-1, a ligand for the Tie-2 receptor, during embryonic angiogenesis. Cell 87 (1996) 1171-1180
143. Suri C., McLain J., Thurston G., McDonald D., Oldmixon E.H., Sato T.N., and Yancopouolos G.D. Increased vascularization in mice overexpressing angiopoietin-1. Science 282 (1998) 468-471
144. Takashima S., Kitakaze M., Asakura M., Asanuma H., Sanada S., Tashiro F., Niwa H., Miyazaki J.J., Hirota S., Kitamura Y., Kitsukawa T., Fujisawa H., et al. Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis. Proc. Natl. Acad. Sci. USA 99 (2002) 3657-3662
145. Tello-Montoliu A., Patel J.V., and Lip G.Y. Angiogenin: A review of the pathophysiology and potential clinical applications. J. Thromb. Haemost. 4 (2006) 1864-1974
146. Thurston G. Role of angiopoietins and Tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis. Cell Tissue Res. 314 (2003) 61-68
147. Thurston G., Suri C., Smith K., McClain J., Stao T.N., Yancoupolos G.D., and McDonald D.M. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286 (1999) 2511-2514
148. Tobe T., Ortega S., Luna J.D., Ozaki H., Okamoto N., Derevjanik N.L., Vinores S.A., Basilico C., and Campochiaro P.A. Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. Am. J. Pathol. 153 (1998) 1641-1646
149. Tsigkos S., Koutsilieris M., and Papapetropoulos A. Angiopoietins in angiogenesis and beyond. Expert Opin. Invest. Drugs 12 (2003) 933-941
150. Uemura A., Ogawa M., Hirashima M., Fujiwara T., Koyama S., Takagi H., Honda Y., Wiegand S.J., Yancopoulos G.D., and Nishikawa S. Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells. J. Clin. Invest. 110 (2002) 1619-1628
151. Urness L.D., Sorensen L.K., and Li D.Y. Arteriovenous malformations in mice lacking activin receptor-like kinase-1. Nat. Genet. 26 (2000) 328-331
152. Uyttendaele H., Marazzi G., Wu G., Yan Q., Sasson D., and Kitajewski J. Notch4/int-3, a mammary proto-oncogene, is an endothelial cell-specific mammalian Notch gene. Development 122 (1996) 2251-2259
153. Veikkola T., Jussila L., Makinen T., Karpanen T., Jeltsch M., Petrova T.V., Kubo H., Thurston G., McDonald D.M., Achen M.G., Stacker S.A., and Alitalo K. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J. 20 (2001) 1223-1231
154. Villa N., Walker L., Lindsell C.E., Gasson J., Iruela-Arispe M.L., and Weinmaster G. Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. Mech. Dev. 108 (2001) 161-164
155. Vittet D., Buchou T., Schweitzer A., Dejana E., and Huber P. Targeted null-mutation in the vascular endothelial-cadherin gene impairs the organization of vascular-like structures in embryoid bodies. Proc. Natl. Acad. Sci. USA 94 (1997) 6273-6278
156. Wang H., Chen Z., and Anderson D. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93 (1998) 741-753
157. Wigle J.T., and Oliver G. Prox-1 function is required for the development of the murine lymphatic system. Cell 98 (1999) 769-778
158. Wijelath R.S., Rahman S., Murray J., Patel Y., Savidge G., and Sobel M. Fibronectin promotes VEGF-induced CD34 differentiation into endothelial cells. J. Vasc. Surg. 39 (2004) 655-660
159. 5 integrin deficient mice. Development 119 (1993) 1093-1105
160. Yang X., Castilla L.H., Xu X., Li C., Gotay J., Weinstein M., Liu P.P., and Deng C.X. Angiogenesis defects and mesenchymal apoptosis in mice lacking SMAD5. Development 126 (1999) 1571-1580
161. Yuan L., Moyon D., Pardanaud L., Breant C., Karkkainen M.J., Alitalo K., and Eichmann A. Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Development 129 (2002) 4797-4806
162. You L.R., Lin F.J., Lee C.T., DeMayo F.J., Tsai M.J., and Tsai S.Y. Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity. Nature 435 (2005) 98-104
163. Zhang T.P., Childs S., Leu J.P., and Fishman M.C. Gridlock signaling pathway fashions in the first embryonic artery. Nature 414 (2001) 216-220
164. Zhou M., Sutliff R.L., Paul R.J., Lorenz J.N., Hoying J.B., Haudenschild C.C., Yin M., Coffin J.D., Kong L., Kranias E.G., Luo W., Boivin G.P., et al. Fibroblast growth factor 2 control of vascular tone. Nat. Med. 4 (1998) 201-207